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Department of Molecular Physics, Leiden University, Leiden, Netherlands, 2 University of Twente, Biophysical Engineering, MESA þ Institute for Nanotechnology, Twente, Netherlands. Sequence-specific information on the fibril-fold of a-synuclein (aS), which is required for understanding fibrilization and the role of aS in Parkinson's disease, is still scarce. Double Electron Electron Resonance (DEER) on doubly spinlabelled aS potentially gives access to distances in the nm-range. Fibrillizing the labelled protein in a background of wild-type aS, intramolecular distances are emphasized, but intermolecular distances cannot be suppressed completely, leading to superposition traces that are difficult to disentangle. Nevertheless, long-range distance constraints are beginning to emerge. We compare distances between residue pairs 56-69, 56-90 and 69-90 1 to recent results of Pornsuwan et al.
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Are these constraints consistent with the simplest model, in which the protein is in a plane perpendicular to the fibril axis, with all b-sheets parallel? If not, it could be that a more complicated fold pertains, such as a situation where not all the b-sheets are parallel to each other or that the protein extends over different planes along the fibril axis. Also, different fibril forms, e.g. different morphologies, could be the cause. We will discuss these possibilities. However, their low concentration and transient nature under physiological conditions have thwarted efforts to determine their structure. Using time resolved FRET spectroscopy, we have recently shown that the monomers are relatively unstructured, and the aggregation process starts with the two terminals of the peptide coming closer in the small oligomers (n-mers with n<10)1. Here we develop a method which combines rapid fluorescence techniques with slower two-dimensional solid state NMR, and probe nascent Ab40 oligomers which demonstrate an enhanced ability to attach to cell membranes compared to the monomers2. We find that the conformation of the two hydrophobic arms (residues 10-22 and 29-40) have already reached the conformation observed in the fibrils. However, the turn region (residues 23 to 28) and the N-terminal tail (residues 1-9) are strikingly different. Notably, majority of the Ab mutants linked to familial AD map to these two regions, and toxicity modulators such as Zn þþ affect the same region3. Our results provide specific structural targets for therapeutic strategies designed to modulate Ab oligomers. Amyloid b (Ab) monomers represent the base state in the pathways of aggregation that result in the fibrils and oligomers involved in Alzheimer's disease (AD). The structural properties of these intrinsically disordered peptides remain unclear despite extensive efforts to resolve these through experiment and computation. Comparison of all-atom, explicitly solvated simulations of wild type Ab monomers simulated with different force fields (OPLS-AA/L and AMBER99sb-ILDN) and water models (TIP3P and TIP4P-Ew) nevertheless demonstrate a convergence in structural properties and good agreement with experimental NMR observables. In Ab42, antiparallel b-hairpin structure between L17-A21, A30-L34, and V40-I41 is prevalent in these ensembles. While residues 21-30 forms an interceding region in both simulations that rarely interacts with the majority of the protein, the structure of this region and the electrostatic interactions that characterize it are notably different between the two. To further explore these differences, NMR experiments and simulations using both combinations have been conducted for familial AD (FAD) mutations that perturb residues 22 and 23, observed in our wild type Ab simulation data to be pivotal in determining the structure of this central region. The characterizations made here suggest simulation conditions that best reproduce the experimental data and help clarify how FAD mutations drive Ab to aberrant aggregation pathways that result in disease phenotypes. Although the natural tendency of proteins is to acquire soluble native-like functional states, they are able to undertake alternative pathways, such as self-association into ordered insoluble amyloid fibrils. The latter are protein aggregates that share common cross-b sheet structures and give rise to various incurable disorders, such as Alzheimer's and Parkinson's diseases. The abnormal self-assembly of amyloid beta (Ab), an intrinsically disordered peptide, into neurotoxic oligomers and fibrils is strongly associated with Alzheimer's disease, thus prompting a comprehensive search for small compounds capable of inhibiting its aggregation. Although many compounds have been reported with this effect, the mechanisms by which they act are still largely unclear. In the present study, we use Small-Angle X-Ray Scattering (SAXS) as a high-throughput tool to screen an in-house fragment-based library in an attempt to identify new potential inhibitors targeting Ab aggregation. We follow the fibrillation process of Ab in solution over time in order to resolve major coexisiting species and monitor by SAXS the effect of small compounds on these species. This approach is expected to provide molecular insights into Ab selfassembly mechanism and lead effectively to much needed new treatment options.
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